Humana cut its earnings outlook to $6.52 a share for the year, down from a previous forecast of at least $8.36 a share. The revision reflects ongoing earnings headwinds from lower Medicare Advantage Star Ratings for 2026.\n\nOn an adjusted basis, Humana maintained its guidance for earnings of at least $9 a share. The company had previously warned that earnings would decline in 2026 due to the lower Medicare Advantage Star Ratings it received, which affect bonus payments tied to the quality scores on a scale of one to five stars.\n\nDespite the outlook cut, Humana continues to expect individual Medicare Advantage membership growth of about 25%, driven by new sales, improved retention, and changes to its customer service approach.